ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, China
Contact: Study coordinator (Lin Shen, MD) · doctorshenlin@sina.cn · 86-010-88196340

Study leads

Lin Shen, MD
Principal Investigator
Peking University Cancer Hospital & Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer · Locally Advanced · Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Los Angeles, United States

Study of ZGGS34 in Participants With Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Zhengzhou, China

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Atlanta, United States